Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemopure for Tissue Preservation in CABG
NCT00301535Phase 2Unknown
- Sponsor
- Biopure
- Start
- Feb 2006
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of hemoglobin glutamer-250 in coronary artery disease (CAD), sponsored by Biopure. Status: unknown.
02
Drugs
hemoglobin glutamer-250
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00301535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301535.